Epstein-Barr virus LMP2A interferes with global transcription factor regulation when expressed during B-lymphocyte development.
about
Epstein-Barr virus-encoded LMP2A induces an epithelial-mesenchymal transition and increases the number of side population stem-like cancer cells in nasopharyngeal carcinoma.LY294002 may overcome 5-FU resistance via down-regulation of activated p-AKT in Epstein-Barr virus-positive gastric cancer cells.Epstein-Barr virus LMP2A alters in vivo and in vitro models of B-cell anergy, but not deletion, in response to autoantigen.Epstein-Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras/PI3K/Akt pathway.Suppression of the LMP2A target gene, EGR-1, protects Hodgkin's lymphoma cells from entry to the EBV lytic cycle.Epstein-Barr virus-associated lymphomas.Epstein-Barr virus LMP2A enhances B-cell responses in vivo and in vitroItchy, a Nedd4 ubiquitin ligase, downregulates latent membrane protein 2A activity in B-cell signaling.Functional similarity analysis of human virus-encoded miRNAs.Somatic hypermutation patterns in germinal center B cell malignancies.A shared gene expression signature in mouse models of EBV-associated and non-EBV-associated Burkitt lymphomaLatent Membrane Protein LMP2A Impairs Recognition of EBV-Infected Cells by CD8+ T Cells.Epstein-Barr virus latent membrane protein 2A mediates transformation through constitutive activation of the Ras/PI3-K/Akt Pathway.Transcriptome changes induced by Epstein-Barr virus LMP1 and LMP2A in transgenic lymphocytes and lymphoma.An auto-regulatory loop for EBV LMP2A involves activation of Notch.Epstein-Barr virus latent membrane protein 2A preferentially signals through the Src family kinase LynEpstein-Barr virus latent membrane protein 2A activates beta-catenin signaling in epithelial cells.Epstein-Barr virus latent membrane protein 2A exploits Notch1 to alter B-cell identity in vivo.cAMP stringently regulates human cathelicidin antimicrobial peptide expression in the mucosal epithelial cells by activating cAMP-response element-binding protein, AP-1, and inducible cAMP early repressor.EBV may be expressed in the LP cells of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) in both children and adultsRegulation of angiogenesis in malignancies associated with Epstein-Barr virus and Kaposi's sarcoma-associated herpes virus.Epstein-Barr virus-encoded LMP2A regulates viral and cellular gene expression by modulation of the NF-kappaB transcription factor pathway.Pathogen manipulation of B cells: the best defence is a good offence.Cellular gene expression survey of vaccinia virus infection of human HeLa cells.Efficacy of recombinant adenovirus expressing a fusion gene from GM-CSF and Epstein-Barr virus LMP2A in a mouse tumor model.Attenuated liver fibrosis in the absence of B cellsConstruction of a recombinant-BCG containing the LMP2A and BZLF1 genes and its significance in the Epstein-Barr virus positive gastric carcinoma.B cell receptor signal strength determines B cell fate.Viral subversion of B cell responses within secondary lymphoid organs.IL-17A and IL-17F Expression in B LymphocytesEpstein-Barr Virus-Associated Malignancies: Roles of Viral Oncoproteins in Carcinogenesis
P2860
Q33598586-E22094E7-9C0F-4797-AAAD-A500435DF9EFQ33655676-60C09A63-70AD-4D60-853F-FA76E73C67EBQ33843054-A406AA80-1F7E-4548-8664-928BC65250ADQ34347586-369FA77E-C480-4B50-87CA-9382F4A0E992Q34650591-ED5C2DE4-CC22-4509-9918-607086FC6E50Q34651670-AC7022B6-A58E-4328-A6C9-97167EFB7E19Q34717880-A4A14B79-2462-4FF1-849E-0809716C1372Q34975783-6B579C79-C671-49F9-AA80-F564DA80F7AAQ35189091-70DAED1B-FFA6-41D1-8DC8-176AFBFD7FF3Q35552528-05B651A3-CBCD-418B-8A43-CBB6912B0D60Q35631310-589B64B0-287F-4BD1-859F-1CE5091E4B9CQ35661383-D3B7B438-B63E-44F0-B36C-B2A2D118DC64Q35948025-9900C50F-C957-4C14-B39C-225618D2667AQ36250603-57B552AC-2AF8-4C3E-88B5-9EBB90CEF93CQ36528115-F46A7030-9E47-4AF5-9DC7-911B0C265BADQ36845865-1FED02F8-B77D-483F-B94C-8CF77ECA4C9DQ36890676-630D2F6F-6A03-41BF-8D30-7E5B836B65F8Q37039112-04DF3C98-7AD6-476E-906B-6C45637E9BA8Q37372125-CD86F3C7-C008-4860-9415-14C1D49849C5Q37589686-943278FE-1EB0-4CE3-90FC-FC6F2D38DFBAQ37590325-719043DE-2318-4AD7-8623-6EEC23B56797Q37595549-360D83BD-979F-4636-BC3B-85C5623873BFQ38346756-C47699D7-90F7-446F-99E7-B3CAAD9B7BD1Q39752440-F57A0472-4089-493D-A456-B14BDFF25DFEQ40047749-FAF3DEEF-0568-4CD7-89F6-691DAF24ECCAQ42018300-15AAC3E7-3C3C-49B4-8091-3EE448B84BA4Q42226962-B644486D-87A6-46CD-AA33-D0BDC05C9394Q47221910-ADC619EE-D719-44DB-8558-EA1AE37FF1FEQ47564581-E9572247-2646-4218-9C46-055CB74A4951Q57247332-DDCBA742-0117-4F99-B924-0ADF899A91BBQ58803477-CC53324A-0C89-4330-96F7-01D364B4104C
P2860
Epstein-Barr virus LMP2A interferes with global transcription factor regulation when expressed during B-lymphocyte development.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Epstein-Barr virus LMP2A inter ...... ring B-lymphocyte development.
@ast
Epstein-Barr virus LMP2A inter ...... ring B-lymphocyte development.
@en
Epstein-Barr virus LMP2A inter ...... ring B-lymphocyte development.
@nl
type
label
Epstein-Barr virus LMP2A inter ...... ring B-lymphocyte development.
@ast
Epstein-Barr virus LMP2A inter ...... ring B-lymphocyte development.
@en
Epstein-Barr virus LMP2A inter ...... ring B-lymphocyte development.
@nl
prefLabel
Epstein-Barr virus LMP2A inter ...... ring B-lymphocyte development.
@ast
Epstein-Barr virus LMP2A inter ...... ring B-lymphocyte development.
@en
Epstein-Barr virus LMP2A inter ...... ring B-lymphocyte development.
@nl
P2860
P1433
P1476
Epstein-Barr virus LMP2A inter ...... ring B-lymphocyte development.
@en
P2093
Richard Longnecker
Toni Portis
P2860
P304
P356
10.1128/JVI.77.1.105-114.2003
P407
P577
2003-01-01T00:00:00Z